GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

Commerzbank AG (ETR: CBKG) on Wednesday reported revenues that surpassed consensus estimates by about €55 million, due to ...

Investing.com - European stock markets rose Wednesday, following the lead from Wall Street, as Republican candidate Donald Trump looked set to win the US presidential election. At ...